Proof of Usefulness Report

EveliQure Biotechnologies

Analysis completed on 2/6/2026

+326
Proof of Usefulness Score
Certified Problem Solver

EveliQure Biotechnologies is a legitimate Austrian biotech company (Series A funded, ~€9M+) developing a promising Shigella/ETEC vaccine (ShigETEC). However, the submission itself is of very low quality, containing factually incorrect claims ('most people have used my product' is impossible for a Phase 1 clinical stage company) and suspicious contact details ('SwiftHeart', numeric email). While the underlying technology and utility are high, the 'Proof' is diminished by the reliability of the submission and the early clinical stage of the product compared to established market traction.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+13.13
Audience Reach Impact+1.00
Technical Innovation+12.75
Evidence Of Traction+3.75
Market Timing Relevance+7.50
Functional Completeness+0.25
Subtotal383.8)
Usefulness Multiplierx0.85 (High uncertainty due to submitter credibility)
Final Score+326

Project Details

Project URL
eveliqure.com
Description
Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries. Eveliqure is a game-changer amongst vaccine companies, championing novel technologies to make the world safe from diarrhoea. Eveliqure is passionate about improving the quality of life for both the poor and the privileged by providing innovative medical solutions that fight diarrhoeal diseases.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline